Company / Gross Profit
Bio-Techne Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$790.3M
FY2025
5-year range
$473.5M / $790.3M
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#44 of 100
Health Care
What the data says
At $790M, Bio-Techne's gross profit ranks #44 of 100 in the Health Care sector. Gross Profit has increased for 4 consecutive years, from $473M in FY2021 to $790M in FY2025.
Based on SEC 10-K filings.
$790M in FY2025 with a 5-year CAGR of +10.3%.
Improved from $633M to $790M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +17.8%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
#44 of 100 in Health CareTop 44% of 100This company $790.3M Sector average $1.8B
▼
-56.5% below sector average
Key checks
Key Insights
- Bio-Techne's gross profit has grown for 4 consecutive years.
- 5-year CAGR of +10.3%, indicating consistent growth.
- In FY2025, gross profit increased 2.7% year-over-year.
- Ranks #44 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $790.3M | +2.7% |
| FY2024 | $769.7M | +21.6% |
| FY2023 | $632.9M | +31.0% |
| FY2022 | $483.2M | +2.0% |
| FY2021 | $473.5M | -2.0% |
| FY2020 | $483.2M | +2.0% |
| FY2019 | $473.5M | +9.6% |
| FY2018 | $432.1M | +15.4% |
| FY2017 | $374.5M | +11.3% |
| FY2016 | $336.7M | +9.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026